双重促炎细胞因子阻断增强急性GVHD疗效并保留GVT效应
该研究在小鼠GVHD模型中评估TNF与IL-6R双重阻断对GVHD及GVT效应的影响。早期联合阻断较单药阻断更显著保护急性肠道GVHD并提高生存率,且保留GVT效应,提示GVHD与GVT可分离。
要点
- 早期联合阻断TNF和IL-6R较单药更有效保护急性肠道GVHD并改善生存。
- 双重细胞因子阻断保留移植物抗肿瘤效应。
- GVHD与GVT效应可被区分,联合阻断可能提高allo-HSCT疗效。
核心结论
- 早期联合阻断TNF和IL-6R对急性肠道GVHD的保护和生存获益优于单药阻断,且保留GVT效应。
研究设计与样本
- 在不同小鼠GVHD模型中评估TNF与IL-6R双重阻断对GVHD及GVT效应的影响。
主要发现
- 早期联合阻断较单药阻断对急性肠道GVHD提供更强保护和生存获益。
- 联合阻断还减少后期慢性皮肤GVHD的发生。
- 双重细胞因子阻断保留GVT效应。
临床怎么用
- GVHD与GVT效应可被区分,联合阻断TNF和IL-6R可能提高allo-HSCT疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a potential curative option for treating a variety of hematologic diseases, but acute and chronic graft-versus-host disease (GVHD) remain major barriers limiting efficacy. Acute gut GVHD occurs with marked increases in proinflammatory cytokines (including TNF and IL-6), which we recently demonstrated was exacerbated in obesity resulting in severe gastrointestinal pathology. Given the pleiotropic and overlapping effects of these 2 cytokines, we assessed the impact of dual TNF and IL-6R blockade on GVHD as well as graft-versus tumor (GVT) effects in different mouse GVHD models. Early administration of combined blockade resulted in greater protection and survival from acute gut GVHD compared with single blockade regimens and even development of later chronic skin GVHD. Importantly, double cytokine blockade preserved GVT effects reinforcing that GVT and GVHD can be delineated and may result in greater efficacy in allo-HSCT.
引用
- Khuat LT, Vick LV, Dunai C, et al. Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects. Blood. 2021. PMID: 34424962. doi:10.1182/blood.2021011216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。